Analysis of the Aurobindo Pharma stock that is listed on BSE/NSE. Includes return ratios and piotroski scores to understand financial stability of the stocks
Text of Aurobindo Pharma - Pharma stock analysis
BSE Code : 524804NSE Code : AUROPHARMASector : PHARMACEUTICALSReport date : Sun Apr 13 10:42:08 EDT 2014
Market CapMarket Cap is the price ofall the outstandingcommon shares if we wereto buy it all at the currentprice
The benchmark companySun Pharma in thepharmaceuticals sector is8 times the size ofAurobindo Pharma
Large Caps are a choicefor people who want Lowvolatility/risk with stablereturns and high liquidity
Stock AnalysisGrowth AnalysisCompanies that have grown historically are more likely to exibit similar growth in the future. Readthe trends in the 4 year annualized profit growth, book value growth and sales growth shownbelow:
How good are the returns?RoE is the speed at which the company might grow without sorting to additional fund raising.RoCE is the growth speed, if the company used all the assets, including loans/preference shares.The 2-year and 4-year values give a reasonable assurance about the growth sustenance.
Piotroski ScoreSeperate Winners from LosersThe Piotroski scoring system is a nine point system to determine the strength of a firm's financialposition. The score was developed by an accounting professor out of Chicago named JosephPiotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.
Stock AnalysisGrowth AnalysisHow good are the returns?